MaxCyte Q4 Earnings Miss Estimates, Shares Down 51.2% YTD

martes, 24 de marzo de 2026, 6:42 pm ET1 min de lectura
MXCT--

MaxCyte, Inc. reported a Q4 loss of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.08. The company missed revenue estimates with $7.3 million, down 17.98% YoY. Shares have lost 51.2% this year. The Zacks Rank is #3 (Hold), indicating a neutral outlook for the stock.

MaxCyte Q4 Earnings Miss Estimates, Shares Down 51.2% YTD

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios